DocDollars

Alimera Sciences, Inc.

GA · United States · Reporting entity ID 100000056293

Total reported 2019–2025
$4.66M
#735 of 2,960 reporting companies — 0% of all reported industry payments
$3.29M in general payments across 17,309 records, plus $1.37M in research funding across 375 records.

How it breaks down

General payments $3,293,484
Research funding $1,370,612

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Alimera Sciences, Inc. reported $4.66M to US doctors and teaching hospitals from 2019 to 2025, ranking #735 of 2,960 reporting companies. 29% of that was research funding and 71% general payments such as consulting, speaking, food and travel. 17,309 general payment records and 375 research records were filed.

Common questions about Alimera Sciences, Inc.

How much has Alimera Sciences, Inc. paid US doctors?

Alimera Sciences, Inc. reported $4,664,096 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $3,293,484 in general payments, $1,370,612 in research funding.

How does Alimera Sciences, Inc. rank among drug and device companies?

It ranks #735 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Alimera Sciences, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.